Ars Investment Partners, LLC Chembio Diagnostics, Inc. Transaction History

Ars Investment Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$3.4 - $7.97 $110,160 - $258,228	-32,400 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$4.11 - $7.51 $133,164 - $243,324	32,400 New	32,400 $154,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $84,446 - $152,673	-25,746 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$3.18 - $15.54 $647,737 - $3.17 Million	-203,691 Reduced 88.78%	25,746 $84,000
Q1 2020 May 12, 2020	SELL	$2.36 - $5.6 $244,234 - $579,538	-103,489 Reduced 31.08%	229,437 $1.18 Million
Q4 2019 Feb 12, 2020	SELL	$3.94 - $5.76 $498,863 - $729,302	-126,615 Reduced 27.55%	332,926 $1.52 Million
Q3 2019 Nov 14, 2019	SELL	$4.84 - $7.25 $301,464 - $451,573	-62,286 Reduced 11.94%	459,541 $2.81 Million
Q2 2019 Aug 12, 2019	BUY	$5.56 - $7.85 $114,652 - $161,874	20,621 Added 4.11%	521,827 $3.18 Million
Q1 2019 May 09, 2019	SELL	$5.32 - $7.18 $806,926 - $1.09 Million	-151,678 Reduced 23.23%	501,206 $2.78 Million
Q4 2018 Feb 13, 2019	SELL	$4.95 - $10.5 $1.11 Million - $2.36 Million	-224,740 Reduced 25.61%	652,884 $3.7 Million
Q3 2018 Nov 13, 2018	BUY	$9.2 - $11.5 $747,564 - $934,455	81,257 Added 10.2%	877,624 $9.22 Million
Q2 2018 Aug 13, 2018	SELL	$7.8 - $11.1 $496,353 - $706,348	-63,635 Reduced 7.4%	796,367 $8.84 Million
Q1 2018 May 04, 2018	SELL	$7.05 - $9.0 $91,417 - $116,703	-12,967 Reduced 1.49%	860,002 $6.88 Million
Q4 2017 Feb 14, 2018	BUY	$5.95 - $8.35 $521,374 - $731,677	87,626 Added 11.16%	872,969 $7.16 Million
Q3 2017 Nov 14, 2017	BUY	$5.85 - $6.2 $4.59 Million - $4.87 Million	785,343	785,343 $4.87 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.